British researchers have developed the first AI-designed vaccine aimed at providing broad protection against evolving viruses. This innovative vaccine, which uses a super-antigen and a needle-free delivery method, has shown promising results in initial human trials. The next phase will expand testing to ensure its effectiveness across diverse populations.